E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/11/2013 in the Prospect News Investment Grade Daily and Prospect News Liability Management Daily.

Boston Scientific calls entire $1.45 billion of 5.45%, 4.5% notes

By Tali David

Minneapolis, Sept. 11 - Boston Scientific Corp. plans to redeem all $600 million of its 5.45% notes due June 15, 2014 and all $850 million of its 4.5% notes due Jan. 15, 2015, according to two notices.

The 5.45% notes will be redeemed at 105.206 and the 4.5% notes will be redeemed at 103.934 on Sept. 12.

On Aug. 8, the company said it planned to use the proceeds of two note offerings to redeem all or a portion of the 5.45% notes and 4.5% notes.

The Bank of New York Mellon Trust Co., NA is the trustee agent.

Boston Scientific is a medical device maker based in Natick, Mass.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.